+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Comparing polymethylmethacrylate implant with collagen implant in deep sclerectomy: a randomized controlled trial



Comparing polymethylmethacrylate implant with collagen implant in deep sclerectomy: a randomized controlled trial



Journal of Glaucoma 15(3): 264-270



To compare the intraocular pressure (IOP) lowering effect and safety of a new rigid, nonabsorbable polymethylmethacrylate implant (PMMA) with the commercially available cylindrical collagen implant used in deep sclerectomy procedure. Nonpenetrating deep sclerectomy was performed on all patients. Patients were randomly assigned to receive either a PMMA implant or a collagen implant. The trial involved 60 patients (60 eyes) with medically uncontrolled primary and secondary open-angle glaucoma who were randomized to receive either a PMMA implant (30 eyes) or the collagen implant (30 eyes). The patients were examined before and after the operation 1 day before surgery and at day 1; weeks 1, 2 and 3; and months 1, 2, 3, 6, 9, 12, 18, 24, and 30. At each visit, the following examinations were performed: slit lamp examination, tonometry, visual acuity, and fundoscopy. The mean follow-up period was 20.4 (SD 12.4) months (PMMA) and 15.1 (SD 7.7) months (collagen) (P=NS). The mean preoperative IOP was 21.4 (SD 7.1) mm Hg (PMMA) and 21.0 mm Hg (SD 5.4) (collagen). The mean postoperative IOP was 7.4 (SD 4.5) mm Hg (PMMA) and 5.4 (SD 4.4) mm Hg (collagen) at day 1 (P=NS), 15.7 (SD 5.0) mm Hg (PMMA) and 14.7 (SD 5.0) mm Hg (collagen) at month 1 (P=NS), and 13.8 (SD 4.8) mm Hg (PMMA) and 13.3 (SD 2.4) mm Hg (collagen) at month 12 (P=NS). Seven patients had perforations of the trabeculo-Descemet membrane and were excluded from the analysis. At the last follow-up visit, 42% of PMMA patients and 44% of collagen patients achieved an IOP of 21 mm Hg or less without medication (P=NS). The number of medications was reduced from 2.4 (SD 1.0) to 0.6 (SD 0.6) (P<0.001) in the PMMA group, and from 2.4 (SD 1.1) to 0.7 (SD 0.8) (P<0.001) in the collagen group. There were no significant differences between the 2 groups in postoperative and transient complications. The new PMMA implant offered success and complication rates equal to those of the collagen implant. The new PMMA implant could serve as a low-cost alternative to the collagen implant and render the use of deep sclerectomy with an implant affordable for settings with limited financial resources.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 048599386

Download citation: RISBibTeXText

PMID: 16778652

DOI: 10.1097/01.ijg.0000212211.33265.6d


Related references

Comparing deep sclerectomy with collagen implant to the new method of very deep sclerectomy with collagen implant: a single-masked randomized controlled trial. Journal of Glaucoma 19(1): 24-30, 2010

Randomised controlled clinical trial comparing a rigid polymethyl methacrylate implant with the collagen implant in non penetrating deep sclerectomy. ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 1187, 2003

In vivo study comparing an X-shaped polymethylmethacrylate and a cylindrical collagen implant for deep sclerectomy. Clinical and Experimental Ophthalmology 39(2): 135-141, 2011

Effect of different application depths of mitomycin-C in deep sclerectomy with collagen implant: a randomized controlled trial. Clinical and Experimental Ophthalmology 37(3): 286-292, 2009

Comparing Deep Sclerectomy With Collagen Implant With the New Method of Very Deep Sclerectomy With Collagen Implant. Journal of Glaucoma 20(1): 67-68, 2011

Phaco-deep Sclerectomy with Collagen Implant Compared to Deep Sclerectomy with Collagen Implant Medium Term Results. ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 3351, 2002

Supraciliary versus intrascleral implantation with hema implant (Esnoper V-2000) in deep sclerectomy: a multicenter randomized controlled trial. Acta Ophthalmologica 96(7): E852-E858, 2018

Cross shaped pmma implant versus collagen cylindrical implant in deep sclerectomy in an animal model. ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 1209, 2003

Deep Sclerectomy in one eye versus Deep Sclerectomy with Collagen Implant in the contralateral eye of the same patient Long term Follow-up. ARVO Annual Meeting Abstract Search & Program Planner : Abstract No 868, 2002

Profilometric changes of peri-implant tissues over 5 years: A randomized controlled trial comparing a one- and two-piece implant system. Clinical Oral Implants Research 29(8): 864-872, 2018

Deep sclerectomy in one eye vs deep sclerectomy with collagen implant in the contralateral eye of the same patient: long-term follow-up. Eye 19(3): 298-302, 2004

A randomized controlled clinical trial comparing guided with nonguided implant placement: A 3-year follow-up of implant-centered outcomes. Journal of Prosthetic Dentistry 2019, 2019

Deep sclerectomy without absorbable implant and with unsutured superficial flap Prospective randomized clinical trial vs trabeculectomy with releasable sutures. IOVS 40(4): S269, March 15, 1999

Deep sclerectomy: results with and without collagen implant. International Ophthalmology 20(1-3): 157-162, 1996

Nd:Yag goniopuncture after deep sclerectomy with collagen implant. Ophthalmic Surgery and Lasers 30(2): 120-125, 1999